These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9923826)

  • 21. [Trial of chemotherapy with a new antimitotic derivative].
    Chauvergne J
    Nouv Presse Med; 1973 Mar; 2(9):581. PubMed ID: 4703337
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I study of liposomal daunorubicin in relapsed and refractory acute myeloid leukemia.
    Bieker R; Lerchenmüller C; Wehmeyer J; Serve HL; Mesters RM; Büchner T; Berdel WE
    Oncol Rep; 2003; 10(4):915-20. PubMed ID: 12792745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.
    Yeo W; Chan KK; Mukwaya G; Ross M; Leung WT; Ho S; Chan AT; Johnson PJ
    Cancer Chemother Pharmacol; 1999; 44(2):124-30. PubMed ID: 10412946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A pilot study of high-dose zorubicin in advanced stages of soft tissue sarcoma in adults].
    Jelić S; Tomasević Z; Kreacić M; Kovcin V; Radosavljević D; Vlajić M
    Bull Cancer; 1996 Dec; 83(12):1002-7. PubMed ID: 9116363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal daunorubicin: new preparation. Kaposi's sarcoma: occasional remission.
    Prescrire Int; 1998 Apr; 7(34):41-2. PubMed ID: 10183380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
    Cabriales S; Bresnahan J; Testa D; Espina BM; Scadden DT; Ross M; Gill PS
    Oncol Nurs Forum; 1998; 25(1):67-70. PubMed ID: 9460774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer.
    Rose PG
    Oncologist; 2005 Mar; 10(3):205-14. PubMed ID: 15793224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High concentration of Daunorubicin and Daunorubicinol in human malignant astrocytomas after systemic administration of liposomal Daunorubicin.
    Albrecht KW; de Witt Hamer PC; Leenstra S; Bakker PJ; Beijnen JH; Troost D; Kaaijk P; Bosch AD
    J Neurooncol; 2001 Jul; 53(3):267-71. PubMed ID: 11718259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NeXstar Pharmaceuticals lauches DaunoXome.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):52. PubMed ID: 11363700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia.
    Pea F; Russo D; Michieli M; Baraldo M; Ermacora A; Damiani D; Baccarani M; Furlanut M
    Cancer Chemother Pharmacol; 2000; 46(4):279-86. PubMed ID: 11052625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on pharmaceutical characterization and pharmacokinetics of daunorubicin long-circulating liposomes in rat].
    Zhang H; Qi XR; Zhang Q
    Yao Xue Xue Bao; 2002 Apr; 37(4):299-303. PubMed ID: 12579828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unforeseen Severe Cardiotoxicity Associated With Daunorubicin Chemotherapy Even at a Dose Previously Thought to Be Safe: A Case Report.
    Juan MCY; Jones RT; Thabolingam RC
    Am J Ther; 2017; 24(4):e503-e504. PubMed ID: 27272204
    [No Abstract]   [Full Text] [Related]  

  • 34. [The therapeutic efficacy and toxicity of the liposomal form of daunorubicin (Daunoxome) in lymphosarcoma patients].
    Medvedev PV; Nikitin EA; Pivnik AV
    Ter Arkh; 2000; 72(7):38-42. PubMed ID: 10983319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
    Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
    Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
    Versluis AJ; Rump ET; Rensen PC; van Berkel TJ; Bijsterbosch MK
    J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chest and back pain associated with a six-hour infusion of liposomal daunorubicin.
    Hui YF; Cortes JE
    Ann Pharmacother; 2000 Jun; 34(6):810-1. PubMed ID: 10860143
    [No Abstract]   [Full Text] [Related]  

  • 38. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M
    Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemotherapy protocol "8 drugs in 1 day" in patients with recurrent malignant glioma].
    Jeremić B; Grujicić D; Matović M
    Srp Arh Celok Lek; 1994; 122(3-4):73-5. PubMed ID: 17972813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
    Kaledin VI; Il'nitskaia SI
    Vopr Onkol; 1996; 42(3):64-6. PubMed ID: 8801744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.